Metabolic Effects of Natriuretic Peptide Hormones

NCT03397966 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

FED

Sponsor class

Stopped Study drug no longer available

Conditions

Obesity
Cardiovascular Physiological Phenomena
Metabolism

Interventions

DRUG: recombinant human BNP(1-32)
DRUG: placebo (control, normal saline)

Sponsor

VA Office of Research and Development